当前位置:首页 - 行情中心 - 信邦制药(002390) - 财务分析 - 现金流量表

信邦制药

(002390)

  

流通市值:75.76亿  总市值:76.39亿
流通股本:19.28亿   总股本:19.44亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,392,910,428.842,916,946,301.831,380,057,674.156,285,555,281.01
  收到其他与经营活动有关的现金96,340,560.9491,226,791.4865,040,786.7103,414,416.11
  经营活动现金流入小计4,489,250,989.783,008,173,093.311,445,098,460.856,388,969,697.12
  购买商品、接受劳务支付的现金3,053,053,427.032,134,493,536.851,032,022,830.774,287,605,550.34
  支付给职工以及为职工支付的现金544,680,196.39377,438,379.22209,842,541.7739,764,377.72
  支付的各项税费161,804,358.2895,985,631.8147,420,555.96222,006,002.93
  支付其他与经营活动有关的现金268,130,705.72172,829,897.63100,792,467.83504,624,803.54
  经营活动现金流出小计4,027,668,687.422,780,747,445.511,390,078,396.265,754,000,734.53
  经营活动产生的现金流量净额461,582,302.36227,425,647.855,020,064.59634,968,962.59
二、投资活动产生的现金流量:
  收回投资收到的现金10,000,00010,000,000-3,099,714.53
  取得投资收益收到的现金341,843.03304,964.14101,384.144,083,342.25
  处置固定资产、无形资产和其他长期资产收回的现金净额788,991.7741,194.9105,5002,653,383.51
  投资活动现金流入小计11,130,834.7311,046,159.04206,884.149,836,440.29
  购建固定资产、无形资产和其他长期资产支付的现金66,335,825.5955,902,231.3535,054,206.07124,867,551.15
  投资活动现金流出小计66,335,825.5955,902,231.3535,054,206.07124,867,551.15
  投资活动产生的现金流量净额-55,204,990.86-44,856,072.31-34,847,321.93-115,031,110.86
三、筹资活动产生的现金流量:
  取得借款收到的现金382,000,000358,000,000153,000,000895,100,000
  收到其他与筹资活动有关的现金82,795,072.5682,795,072.5682,795,072.5675,293,204.46
  筹资活动现金流入小计464,795,072.56440,795,072.56235,795,072.56970,393,204.46
  偿还债务支付的现金613,200,000409,300,000120,000,000900,100,000
  分配股利、利润或偿付利息支付的现金219,858,190.48141,295,651.9677,840,630.58226,418,939.66
  其中:子公司支付给少数股东的股利、利润102,534,95073,869,95073,255,00034,128,500
  支付其他与筹资活动有关的现金49,660,193.0148,511,212.3478,668,573.73161,780,925.21
  筹资活动现金流出小计882,718,383.49599,106,864.3276,509,204.311,288,299,864.87
  筹资活动产生的现金流量净额-417,923,310.93-158,311,791.74-40,714,131.75-317,906,660.41
四、汇率变动对现金及现金等价物的影响-1,859.813,735.541,197.23-725.16
五、现金及现金等价物净增加额-11,547,859.2424,261,519.29-20,540,191.86202,030,466.16
  加:期初现金及现金等价物余额932,720,240.84932,720,240.84932,720,240.84730,689,774.68
  期末现金及现金等价物余额921,172,381.6956,981,760.13912,180,048.98932,720,240.84
补充资料:
  净利润-142,445,335.96-155,690,056.99
  资产减值准备-6,287,040.22-71,613,580.23
  固定资产和投资性房地产折旧-92,264,340.2-197,543,689.22
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-92,264,340.2-197,543,689.22
  无形资产摊销-7,410,658.84-14,709,069.22
  长期待摊费用摊销-6,805,008.7-16,891,536.98
  处置固定资产、无形资产和其他长期资产的损失--95,696.33-2,291,981.97
  固定资产报废损失-832,085.64-1,108,572.31
  财务费用-12,446,340.67-26,447,386.46
  投资损失--304,964.14--2,926,543.94
  递延所得税--97,792.34--7,843,316.82
  其中:递延所得税资产减少-14,794.07--7,733,283.01
    递延所得税负债增加--112,586.41--110,033.81
  存货的减少-102,722,036.05--63,636,295.45
  经营性应收项目的减少-57,252,761.75-334,130,512.54
  经营性应付项目的增加--203,361,597.48--116,894,722.61
  不涉及现金收支的投资和筹资活动金额其他项目---1,320,595.15
  现金的期末余额-956,981,760.13-932,720,240.84
  减:现金的期初余额-932,720,240.84-730,689,774.68
  现金及现金等价物的净增加额-24,261,519.29-202,030,466.16
公告日期2025-10-292025-08-302025-04-302025-04-15
审计意见(境内)标准无保留意见
TOP↑